JP6653120B2 - Ｉｋａｒｏｓ阻害に基づく抗炎症薬 - Google Patents

Ｉｋａｒｏｓ阻害に基づく抗炎症薬 Download PDF

Info

Publication number
JP6653120B2
JP6653120B2 JP2015043590A JP2015043590A JP6653120B2 JP 6653120 B2 JP6653120 B2 JP 6653120B2 JP 2015043590 A JP2015043590 A JP 2015043590A JP 2015043590 A JP2015043590 A JP 2015043590A JP 6653120 B2 JP6653120 B2 JP 6653120B2
Authority
JP
Japan
Prior art keywords
ikaros
inflammatory
cells
gene
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015043590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016088926A (ja
JP2016088926A5 (enExample
Inventor
木下　茂
茂 木下
真由美 上田
真由美 上田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of JP2016088926A publication Critical patent/JP2016088926A/ja
Publication of JP2016088926A5 publication Critical patent/JP2016088926A5/ja
Application granted granted Critical
Publication of JP6653120B2 publication Critical patent/JP6653120B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP2015043590A 2014-10-31 2015-03-05 Ｉｋａｒｏｓ阻害に基づく抗炎症薬 Active JP6653120B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014223295 2014-10-31
JP2014223295 2014-10-31

Publications (3)

Publication Number Publication Date
JP2016088926A JP2016088926A (ja) 2016-05-23
JP2016088926A5 JP2016088926A5 (enExample) 2018-03-22
JP6653120B2 true JP6653120B2 (ja) 2020-02-26

Family

ID=56017549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015043590A Active JP6653120B2 (ja) 2014-10-31 2015-03-05 Ｉｋａｒｏｓ阻害に基づく抗炎症薬

Country Status (1)

Country Link
JP (1) JP6653120B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2968628T3 (es) * 2019-09-03 2024-05-13 Square Power Ltd Rebamipida para uso en prevención y tratamiento de la enfermedad de Crohn
CN111961702A (zh) * 2020-07-22 2020-11-20 上海珈蓓生物科技有限公司 植提物抗皮肤感染性炎症反应的细胞学评价方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2123406A1 (en) * 1992-09-14 1994-03-31 Katia Georgopoulos Ikaros: a t cell pathway regulatory gene
JPH1029942A (ja) * 1996-04-02 1998-02-03 Yoichi Ichikawa 慢性関節リウマチ治療剤
WO2010019210A2 (en) * 2008-08-11 2010-02-18 President And Fellows Of Harvard College Halofuginone analogs for inhibition of trna synthetases and uses thereof
ES2872967T3 (es) * 2012-06-29 2021-11-03 Celgene Corp Métodos para determinar la eficacia de fármacos usando IKZF3 (AIOLOS)
WO2015127351A1 (en) * 2014-02-24 2015-08-27 Celgene Corporation Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders

Also Published As

Publication number Publication date
JP2016088926A (ja) 2016-05-23

Similar Documents

Publication Publication Date Title
JP5847590B2 (ja) 生体材料およびその使用
JP5794514B2 (ja) 腫瘍血管新生阻害剤
JP6653120B2 (ja) Ｉｋａｒｏｓ阻害に基づく抗炎症薬
JP2017505763A (ja) 生物学的材料およびその治療用途
JP2015173601A (ja) がん幹細胞の増殖抑制物質のスクリーニング方法
JP7175526B2 (ja) 細胞遊走調節に関する疾患の予防・治療剤および肺間質の疾患の疾患活動性判定・予後評価
JP2011032236A (ja) 腫瘍血管新生阻害剤
JP6029019B2 (ja) 細胞接着阻害剤、細胞増殖阻害剤、並びに癌の検査方法および検査用キット
EP1923072A1 (en) Prophylactic/therapeutic agent for cancer
WO2009084668A1 (ja) 癌細胞増殖阻害方法、増殖阻害剤及びスクリーニング方法
WO2006093337A1 (ja) 癌の予防・治療剤
JP6226315B2 (ja) 炎症性疾患の予防・治療剤、並びに炎症性疾患予防・治療薬のスクリーニング方法
JPWO2016031996A1 (ja) 関節炎の予防・治療剤、検査キット、並びに関節炎予防・治療薬のスクリーニング方法
JP5378202B2 (ja) 脳・神経に特異的あるいは神経分化に特異的なバイオマーカー
JP5669271B2 (ja) 腫瘍血管新生阻害剤
EP2016949A1 (en) Novel use of g-protein-conjugated receptor and ligand thereof
JP2006129724A (ja) ラクリチン活性を有する化合物のスクリーニング方法
JPWO2008102777A1 (ja) インスリン抵抗性改善剤
JPWO2011115271A1 (ja) 腫瘍血管新生阻害剤
JP2014014368A (ja) がんに特異的なバイオマーカー
JP5451376B2 (ja) 血球系に特異的あるいは破骨細胞分化に特異的なバイオマーカー
JPWO2011115268A1 (ja) 腫瘍血管新生阻害剤
JP2011105669A (ja) 抗腫瘍剤および抗腫瘍剤のスクリーニング方法
WO2011019065A1 (ja) 腫瘍血管新生阻害剤

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20150403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180205

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181024

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181211

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190402

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190529

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20191015

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191203

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20191211

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200106

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200127

R150 Certificate of patent or registration of utility model

Ref document number: 6653120

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D04

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250